Literature DB >> 6212535

Further studies of natural killer cell function in Chediak-Higashi patients.

J C Roder, T Haliotis, L Laing, D Kozbor, P Rubin, H Pross, L A Boxer, J G White, A S Fauci, H Mostowski, D S Matheson.   

Abstract

Spontaneous natural killer (NK) activity and antibody-dependent cellular cytotoxicity (ADCC) of blood lymphocytes against five human tumour cell lines (K562, Molt-4, HL-60, Chang, Daudi) and three mouse tumour lines (YAC, P815, RBL-5) were ten- to 100-fold lower than normal in six patients with Chediak-Higashi (CH) disease. NK and ADCC were defective at 4 hr, and less so at 18 hr. The NK activity in normals and CH patients was mediated in part by FcR+, E- effector cells. ADCC against human erythrocytes was normal in CH patients, as were lectin-dependent cytolysis and mixed lymphocyte proliferative responses. Phagocytosis of antibody-coated ox erythrocytes was normal in CH patients as well. These observations confirm that the CH syndrome is associated with a profound and selective defect in NK and ADCC activity against tumour cells, whereas other mononuclear cell-mediated functions are normal.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6212535      PMCID: PMC1555330     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  9 in total

1.  The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.

Authors:  D L Nelson; B M Bundy; H E Pitchon; R M Blaese; W Strober
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

2.  Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): studies in humans and mice.

Authors:  J I Gallin; R J Elin; R T Hubert; A S Fauci; M A Kaliner; S M Wolff
Journal:  Blood       Date:  1979-02       Impact factor: 22.113

3.  The beige mutation in the mouse selectively impairs natural killer cell function.

Authors:  J Roder; A Duwe
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

4.  The Chediak-Higashi syndrome: studies in four patients and a review of the literature.

Authors:  R S Blume; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1972-07       Impact factor: 1.889

5.  Chediak-Higashi syndrome. Observations on the nature of the associated malignancy.

Authors:  P B Dent; L A Fish; L G White; R A Good
Journal:  Lab Invest       Date:  1966-10       Impact factor: 5.662

6.  Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity.

Authors:  H F Pross; M G Baines; P Rubin; P Shragge; M S Patterson
Journal:  J Clin Immunol       Date:  1981-01       Impact factor: 8.317

7.  A new immunodeficiency disorder in humans involving NK cells.

Authors:  J C Roder; T Haliotis; M Klein; S Korec; J R Jett; J Ortaldo; R B Heberman; P Katz; A S Fauci
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

8.  Deficient natural killer cell activity in x-linked lymphoproliferative syndrome.

Authors:  J L Sullivan; K S Byron; F E Brewster; D T Purtilo
Journal:  Science       Date:  1980-10-31       Impact factor: 47.728

9.  A syndrome associating partial albinism and immunodeficiency.

Authors:  C Griscelli; A Durandy; D Guy-Grand; F Daguillard; C Herzog; M Prunieras
Journal:  Am J Med       Date:  1978-10       Impact factor: 4.965

  9 in total
  6 in total

1.  Enlarged dysmorphic lysosomes in an established beige (C57BL/6J;bgJ(/bgJ)) mouse mutant fibroblast line: a reversible characteristic.

Authors:  J B Gow; T A Lyerla; S Lainwala
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-09       Impact factor: 2.416

2.  Identification of mutations in two major mRNA isoforms of the Chediak-Higashi syndrome gene in human and mouse.

Authors:  M D Barbosa; F J Barrat; V T Tchernev; Q A Nguyen; V S Mishra; S D Colman; E Pastural; R Dufourcq-Lagelouse; A Fischer; R F Holcombe; M R Wallace; S J Brandt; G de Saint Basile; S F Kingsmore
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

3.  Natural killer cell activities of patients with breast cancer against different target cells.

Authors:  G Hamilton; A Reiner; B Teleky; E Roth; R Kolb; J Spona; R Jakesz
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 4.  Formation and function of the lytic NK-cell immunological synapse.

Authors:  Jordan S Orange
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

Review 5.  Human immunodeficiency syndromes affecting human natural killer cell cytolytic activity.

Authors:  Hyoungjun Ham; Daniel D Billadeau
Journal:  Front Immunol       Date:  2014-01-21       Impact factor: 7.561

Review 6.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.